drugset / Trial / NCT04599894

Reducing Postoperative Side Effect of Pregabalin

NCT04599894

Phase 4 Completed 58 enrolled The First Hospital of Jilin University
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study was to determine 1) if pregabalin, when given 37.5 mg twice on the day before surgery, would be effective in reducing the early postoperative side effects including dizziness, nausea, vomiting and sedation of receiving pregabalin 75mg two hours pre-operatively and 75mg per day until the third postoperative day; and 2) whether this intervention affected the opioids consumption, and independent transfers at six hours post-op, time to readiness for independent transfers, time to readiness for discharge and pain or not.

Timeline

Start
2020-11-01
Primary completion
2021-04-30
Completion
2021-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg Oral